期刊文献+

CADILLAC和TIMI危险积分对AMI病人病情评估价值的比较研究 被引量:1

Comparison study of value of severity evaluation between CADILLAC and TIMI risk scores to patients with AMI
下载PDF
导出
摘要 目的对比研究TIMI和CADILLAC危险积分对急性心肌梗死(AMI)病人病情评估的价值。方法回顾性分析86例AMI病人的临床资料并分别进行TIMI和CADILLAC危险积分评分,比较两种评分方法不同分数段病死率、主要心脏事件(MACE)发生率的差异,比较TIMI和CADILLAC危险积分对病人病死率、MACE发生率预测的效准度和分辨度的差异。结果AMI病人的TIMI和CADILLAC危险积分在不同分数段(0-2;3-5;≥6分)、不同时间点(14d和30d)内,病死率和MACE发生率有显著性差异(P<0.05);CADILLAC危险积分对应的hosmer-lemeshow拟合优度检验P值明显优于TIMI危险积分,与病人实际病死率更接近,而且CADILLAC对应的AUROCC也明显高于TIMI。对于病人发生AMI14d和30d分别进行比较,在第14天内,TIMI和CADILLAC危险积分对病人病情预测的ROC曲线下面积和hosmer-lemeshow拟合优度检验的P值基本接近,而30d的时间内,则CADILLAC危险积分明显优于TIMI。结论CADILLAC危险积分比TIMI危险积分对AMI病人的病情评估更准确,应该作为一种新的简单、可靠、实用的AMI患者病死危险性预测评分方法在临床推广应用。 [Objective] To compare the value of severity evaluation of patients with acute myocardial infarction (AMI) between CADILLAC and TIMI risk score. [Methods] Data of 86 patients with AMI were gleaned, analyzed and scored with CADILLAC and TIMI risk scores respectively. Difference of mortality and morbidity of MACE among the different score segments were compared in CADILLAC and TIMI risk score respectively. Difference of Calibration and Discrimination of CADILLAC and TIMI risk scores for mortality and morbidity of MACE of patients were compared respectively too. [Results] There had significant difference in mortality and morbidity of MACE among the different score segments(0-2; 3-5; ≥6 score)and different time points (the 14 day; the 30 day) of CADIL- LAC and TIMI risk scores for AMI patients (P 〈0.05). Value of P for hosmer-lemeshow of CADILLAC risk score in mortality of AMI patients was superior to that of TIMI risk score. The mortality predicted with CADILLAC risk score was more closely to actual mortality than that of TIMI risk score. AUROCC of CADILLAC risk score in mortality of AMI patients was higher than that of TIMI risk score too. In the 14 day point of patients in hosptial, Value of P for hosmer-lemeshow and AUROCC for severity evaluation to AMI patients were proximity between CADILLAC and TIMI risk scores, but CADILLAC risk score was superior to that of TIMI risk score in the 30 day point. [Conclusion] CADILLAC risk score was superior to TIMI risk score in evaluating severity and predicting outcome of AMI patients.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第21期3290-3292,共3页 China Journal of Modern Medicine
关键词 TIMI危险积分 CADILLAC危险积分 急性心肌梗死 预后 CADILLAC risk score TIMI risk score acute myocardial infarction outcome
  • 相关文献

参考文献4

  • 1ANTMAN EM,COHEN M,BERMINK PJLM,et al.The TIMI risk score for unstable angina/non-ST elevation MI,a method for prognostication and therapeutic decision making[J].JAMA,2001,20:165-171.
  • 2AMIR H,MANDEEP S,EUGENIA NM,et al.Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction the CADILLAC Risk Score[J].Journal of the American College of Cardiology,2005,45:1397-1405.
  • 3LEMESHOW S,HOSMER DW JR.A review of goodness of fit statistics for use in the development of logistic regression models[J].Am J Epidemiol,1982,115:92-106.
  • 4郑晓英,孟新科,夏小杰,陈绍良,曹克将,方锐,寇清,万丽春.TIMI危险积分与冠状动脉病变的相关性研究(英文)[J].中国现代医学杂志,2003,13(20):43-45. 被引量:1

二级参考文献7

  • 1Elliot MA MDMare Cohen M Peter JLM.BerminkMDet al.the TIMI risk score for unstable angina/non- ST elevation MI. a method for prognostication and therapeutic decision making[J].JAMA(中文版),2001,20(4):165-171.
  • 2Ye Rengao, Lu Zaiying. People' s Sanitary Publishing House: Internal Medicine. June, 2002 the 5th edition,310--312.
  • 3Liu Xianliang, Cui Zhicheng, Flu Dayi, et al. Coronary arteriography and it correlativity with the clinic manifestations in unstable angina peetoris. Chinese Journal of circulation, 2001 , 6 (3) : 306~309.
  • 4Li Jianjun,Jiang Hong,Huang Congxin, et al. The comparison analysis between the level of plasm C reaction protein and coronary, narrowseverity in unstable angina pectoris. Chinese Journal of circulation, 2001 ,6(3): 179.
  • 5Yang Zhijian. Jiangsu Science and technique pulishing house: Intervention cure for CAD. Sept, 2000. 1Ist edition: 19.
  • 6Morrow DA, Antman EM,Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non - Stelevation acute coronary syndrome. Application of the TIMI Risk Score for UA/NSTEMI in PRISM - PLUS. Eur Heart J 2002, 23(3) :223-229.
  • 7Samaha FF, Kimmel SE, Kizer JR,et al. Usefulness of the TIMI risk score in predicting both short - and long - term outcomes in the Veterans Non - Q - Wave Myocardial Infarction Strategies In Hospital (VANQWISH) Trial. Am J Cardiiol, 2002, 90 (9) : 922-926.

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部